Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
Zur Ablage hinzufügen
 Lokale TagsFreigabegeschichteDetailsÜbersicht
  Dynamic Glucose Enhanced MRI at Ultra-High Field in Glioblastoma Patients

Paech, D., Köhler, C., Schuenke, P., Zaiss, M., Windschuh, J., Bonekamp, D., et al. (2016). Dynamic Glucose Enhanced MRI at Ultra-High Field in Glioblastoma Patients. Clinical Neuroradiology, 26(Supplement 1): 196, S20.

Item is

 

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:
Datensatz-Permalink: https://hdl.handle.net/21.11116/0000-0003-601A-4 Versions-Permalink: https://hdl.handle.net/21.11116/0000-0003-601B-3
Genre: Meeting Abstract

Externe Referenzen

einblenden:
ausblenden:
externe Referenz:
https://link.springer.com/content/pdf/10.1007%2Fs00062-016-0531-2.pdf (Verlagsversion)
Beschreibung:
-
OA-Status:

Urheber

einblenden:
ausblenden:
 Urheber:
Paech, D, Autor
Köhler, C, Autor
Schuenke, P, Autor
Zaiss, M1, 2, Autor           
Windschuh, J, Autor
Bonekamp, D, Autor
Bachert, P, Autor
Ladd, M, Autor
Wick, W, Autor
Bendszus, M, Autor
Schlemmer, H-P, Autor
Radbruch, A, Autor
Affiliations:
1Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497796              
2Max Planck Institute for Biological Cybernetics, Max Planck Society, Spemannstrasse 38, 72076 Tübingen, DE, ou_1497794              

Inhalt

einblenden:
ausblenden:
Schlagwörter: -
 Zusammenfassung: Purpose: To investigate if a tumor contrast can be obtained in glioblastoma patients at ultra-high field magnetic resonance imaging (MRI) using simple D-glucose as biodegradable contrast agent.
Patients & Methods: 8 newly diagnosed glioblastoma patients were included in this prospective ethic approved study. Adiabatic chemical exchange sensitive spin-lock (CESL) preparation followed by conventional
MRI readout was realized at a 7 Tesla (7 T) whole-body scanner. 100 ml of 20 % D-glucose were injected manually after 4 minutes baseline measurements yielding the 5 second time-resolved dynamic glucose enhanced (DGE) contrast.
Results: No complication after glucose injection was observed in any patient. In all analyzed patients a DGE contrast was obtained that allowed the identification of the tumor and time-resolved visualization
of intratumoral glucose uptake (Fig. 1). Glucose enhanced signal intensity was significantly increased in glioblastoma tumors compared to contralateral normal appearing white matter (p < 0.001).
Discussion: Our investigations in a homogenous glioblastoma patient
collective showed that simple glucose can be used in ultra-high field DGE imaging as biodegradable contrast agent for the visualization of intracranial tumors generating new insights into tumor metabolism.

Details

einblenden:
ausblenden:
Sprache(n):
 Datum: 2016-09
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: DOI: 10.1007/s00062-016-0531-2
 Art des Abschluß: -

Veranstaltung

einblenden:
ausblenden:
Titel: 51. Jahrestagung der Deutschen Gesellschaft für Neuroradiologie e.V. in Kooperation mit der 24. Jahrestagung der Österreichischen Gesellschaft für Neuroradiologie
Veranstaltungsort: Köln, Germany
Start-/Enddatum: 2016-10-05 - 2016-10-08

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Clinical Neuroradiology
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: -
Seiten: - Band / Heft: 26 (Supplement 1) Artikelnummer: 196 Start- / Endseite: S20 Identifikator: -